Long-term Clinical Outcomes and Safety Profile of SBRT for Centrally Located NSCLC

2017

Baschnagel, 2013, Lung metastases treated with image-guided stereotactic body radiation therapy, Clin Oncol (R Coll Radiol), 25, 236, 10.1016/j.clon.2012.12.005

Fakiris, 2009, Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study, Int J Radiat Oncol Biol Phys, 75, 677, 10.1016/j.ijrobp.2008.11.042

Kelsey, 2013, Stereotactic body radiation therapy for treatment of primary and metastatic pulmonary malignancies, Surg Oncol Clin N Am, 22, 463, 10.1016/j.soc.2013.02.011

Timmerman, 2010, Stereotactic body radiation therapy for inoperable early stage lung cancer, JAMA, 303, 1070, 10.1001/jama.2010.261

Timmerman, 2006, Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer, J Clin Oncol, 24, 4833, 10.1200/JCO.2006.07.5937

Li, 2014, Stereotactic ablative radiotherapy (SABR) using 70 Gy in 10 fractions for non-small cell lung cancer: Exploration of clinical indications, Radiother Oncol, 112, 256, 10.1016/j.radonc.2014.07.010

Nuyttens, 2012, Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors, Radiother Oncol, 102, 383, 10.1016/j.radonc.2011.12.023

Rowe, 2012, Stereotactic body radiotherapy for central lung tumors, J Thorac Oncol, 7, 1394, 10.1097/JTO.0b013e3182614bf3

Pan, 2011, A survey of stereotactic body radiotherapy use in the United States, Cancer, 117, 4566, 10.1002/cncr.26067

Benedict, 2010, Stereotactic body radiation therapy: The report of AAPM Task Group 101, Med Phys, 37, 4078, 10.1118/1.3438081

Chang, 2014, Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: How to fly in a "no fly zone", Int J Radiat Oncol Biol Phys, 88, 1120, 10.1016/j.ijrobp.2014.01.022

Bezjak, 2016, Efficacy and toxicity analysis of NRG Oncology/RTOG 0813 trial of stereotactic body radiation therapy (SBRT) for centrally located non-small cell lung cancer (NSCLC), Int J Radiat Oncol Biol Phys, 96, S8, 10.1016/j.ijrobp.2016.06.035

Bezjak, 2016, Primary study endpoint analysis for NRG Oncology/RTOG 0813 trial of stereotactic body radiation therapy (SBRT) for centrally located non-small cell lung cancer (NSCLC), Int J Radiat Oncol Biol Phys, 1, 5, 10.1016/j.ijrobp.2015.10.040

Roach, 2018, Stereotactic body radiation therapy for central early-stage NSCLC: Results of a prospective phase I/II trial, J Thorac Oncol, 13, 1727, 10.1016/j.jtho.2018.07.017

Tekatli, 2015, Stereotactic ablative radiotherapy (SABR) for central lung tumors: Plan quality and long-term clinical outcomes, Radiother Oncol, 117, 64, 10.1016/j.radonc.2015.09.028

Dunlap, 2010, Size matters: A comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT), J Thorac Cardiovasc Surg, 140, 583, 10.1016/j.jtcvs.2010.01.046

Akthar, 2017, Limitations of PET/CT in the detection of occult N1 metastasis in clinical stage I(T1-2an0) non-small cell lung cancer for staging prior to stereotactic body radiotherapy, Technol Cancer Res Treat, 16, 15, 10.1177/1533034615624045

van Tinteren, 2002, Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: The plus multicentre randomised trial, Lancet, 359, 1388, 10.1016/S0140-6736(02)08352-6

Herder, 2006, Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: A Dutch cooperative randomized study, J Clin Oncol, 24, 1800, 10.1200/JCO.2005.02.4695

Samson, 2018, Local control for clinical stage I non-small cell lung cancer treated with 5-fraction stereotactic body radiation therapy is not associated with treatment schedule, Pract Radiat Oncol, 8, 404, 10.1016/j.prro.2018.04.004